Cargando…
How Should We Test for Lynch Syndrome? A Review of Current Guidelines and Future Strategies
SIMPLE SUMMARY: Carriers of Lynch syndrome (LS) have an increased risk for several types of tumour, in particular bowel and uterine cancers. LS is caused by inheritance of a faulty mismatch repair (MMR) gene, and, in accordance with clinical guidelines, bowel cancers are tested for MMR deficiency to...
Autores principales: | Gallon, Richard, Gawthorpe, Peter, Phelps, Rachel L., Hayes, Christine, Borthwick, Gillian M., Santibanez-Koref, Mauro, Jackson, Michael S., Burn, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865939/ https://www.ncbi.nlm.nih.gov/pubmed/33499123 http://dx.doi.org/10.3390/cancers13030406 |
Ejemplares similares
-
Mismatch repair deficiency testing in Lynch syndrome-associated urothelial tumors
por: Rasmussen, Maria, et al.
Publicado: (2023) -
Detection of Microsatellite Instability in Colonoscopic Biopsies and Postal Urine Samples from Lynch Syndrome Cancer Patients Using a Multiplex PCR Assay
por: Phelps, Rachel, et al.
Publicado: (2022) -
Sebaceous tumours: a prototypical class of skin tumour for universal germline genetic testing
por: Gallon, R., et al.
Publicado: (2021) -
Sequencing‐based microsatellite instability testing using as few as six markers for high‐throughput clinical diagnostics
por: Gallon, Richard, et al.
Publicado: (2019) -
Future collapse: how optimistic should we be?
por: Ehrlich, Paul R., et al.
Publicado: (2013)